Cargando…
Neonatal mouse hippocampus: Phlebotomy-induced anemia diminishes and treatment with erythropoietin partially rescues mammalian target of rapamycin (mTOR) signaling
BACKGROUND: Phlebotomy-induced anemia (PIA) is common in premature infants and affects neurodevelopment. PIA alters hippocampal metabolism in neonatal mice through tissue hypoxia and iron deficiency. The mammalian target of rapamycin (mTOR) pathway senses the status of critical metabolites (e.g., ox...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570638/ https://www.ncbi.nlm.nih.gov/pubmed/28399115 http://dx.doi.org/10.1038/pr.2017.88 |
_version_ | 1783259200058556416 |
---|---|
author | Wallin, Diana J. Zamora, Tara G. Alexander, Michelle Ennis, Kathleen M. Tran, Phu V. Georgieff, Michael K. |
author_facet | Wallin, Diana J. Zamora, Tara G. Alexander, Michelle Ennis, Kathleen M. Tran, Phu V. Georgieff, Michael K. |
author_sort | Wallin, Diana J. |
collection | PubMed |
description | BACKGROUND: Phlebotomy-induced anemia (PIA) is common in premature infants and affects neurodevelopment. PIA alters hippocampal metabolism in neonatal mice through tissue hypoxia and iron deficiency. The mammalian target of rapamycin (mTOR) pathway senses the status of critical metabolites (e.g., oxygen, iron), thereby regulating hippocampal growth and function. We determined the effect of PIA and recombinant human erythropoietin (rHuEpo) treatment on mTOR signaling and expression of genes related to mTOR pathway functions. METHODS: Mice receiving an iron-supplemented diet were phlebotomized from postnatal day (P)3 to a target hematocrit of <25% by P7. Half were maintained at <25% until P14; half received rHuEpo from P7 to increase the hematocrit to 25–28%. Hippocampal phosphorylated to total protein ratios of 4 key mTOR pathway proteins were measured by Western blot at P14 and compared to nonphlebotomized, non-anemic control mice. mRNA levels of genes regulated by mTOR were measured by qPCR. RESULTS: PIA suppressed phosphorylation of all mTOR proteins. rHuEpo restored AMPK and AKT status, and partially rescued the mTOR output protein, S6K. PIA and rHuEpo treatment also altered expression of genes regulated by S6K. CONCLUSIONS: PIA compromises and rHuEpo treatment partially rescues a pathway regulating neuronal DNA transcription, protein translation and structural complexity. |
format | Online Article Text |
id | pubmed-5570638 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
record_format | MEDLINE/PubMed |
spelling | pubmed-55706382017-11-30 Neonatal mouse hippocampus: Phlebotomy-induced anemia diminishes and treatment with erythropoietin partially rescues mammalian target of rapamycin (mTOR) signaling Wallin, Diana J. Zamora, Tara G. Alexander, Michelle Ennis, Kathleen M. Tran, Phu V. Georgieff, Michael K. Pediatr Res Article BACKGROUND: Phlebotomy-induced anemia (PIA) is common in premature infants and affects neurodevelopment. PIA alters hippocampal metabolism in neonatal mice through tissue hypoxia and iron deficiency. The mammalian target of rapamycin (mTOR) pathway senses the status of critical metabolites (e.g., oxygen, iron), thereby regulating hippocampal growth and function. We determined the effect of PIA and recombinant human erythropoietin (rHuEpo) treatment on mTOR signaling and expression of genes related to mTOR pathway functions. METHODS: Mice receiving an iron-supplemented diet were phlebotomized from postnatal day (P)3 to a target hematocrit of <25% by P7. Half were maintained at <25% until P14; half received rHuEpo from P7 to increase the hematocrit to 25–28%. Hippocampal phosphorylated to total protein ratios of 4 key mTOR pathway proteins were measured by Western blot at P14 and compared to nonphlebotomized, non-anemic control mice. mRNA levels of genes regulated by mTOR were measured by qPCR. RESULTS: PIA suppressed phosphorylation of all mTOR proteins. rHuEpo restored AMPK and AKT status, and partially rescued the mTOR output protein, S6K. PIA and rHuEpo treatment also altered expression of genes regulated by S6K. CONCLUSIONS: PIA compromises and rHuEpo treatment partially rescues a pathway regulating neuronal DNA transcription, protein translation and structural complexity. 2017-05-31 2017-09 /pmc/articles/PMC5570638/ /pubmed/28399115 http://dx.doi.org/10.1038/pr.2017.88 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Wallin, Diana J. Zamora, Tara G. Alexander, Michelle Ennis, Kathleen M. Tran, Phu V. Georgieff, Michael K. Neonatal mouse hippocampus: Phlebotomy-induced anemia diminishes and treatment with erythropoietin partially rescues mammalian target of rapamycin (mTOR) signaling |
title | Neonatal mouse hippocampus: Phlebotomy-induced anemia diminishes and treatment with erythropoietin partially rescues mammalian target of rapamycin (mTOR) signaling |
title_full | Neonatal mouse hippocampus: Phlebotomy-induced anemia diminishes and treatment with erythropoietin partially rescues mammalian target of rapamycin (mTOR) signaling |
title_fullStr | Neonatal mouse hippocampus: Phlebotomy-induced anemia diminishes and treatment with erythropoietin partially rescues mammalian target of rapamycin (mTOR) signaling |
title_full_unstemmed | Neonatal mouse hippocampus: Phlebotomy-induced anemia diminishes and treatment with erythropoietin partially rescues mammalian target of rapamycin (mTOR) signaling |
title_short | Neonatal mouse hippocampus: Phlebotomy-induced anemia diminishes and treatment with erythropoietin partially rescues mammalian target of rapamycin (mTOR) signaling |
title_sort | neonatal mouse hippocampus: phlebotomy-induced anemia diminishes and treatment with erythropoietin partially rescues mammalian target of rapamycin (mtor) signaling |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570638/ https://www.ncbi.nlm.nih.gov/pubmed/28399115 http://dx.doi.org/10.1038/pr.2017.88 |
work_keys_str_mv | AT wallindianaj neonatalmousehippocampusphlebotomyinducedanemiadiminishesandtreatmentwitherythropoietinpartiallyrescuesmammaliantargetofrapamycinmtorsignaling AT zamoratarag neonatalmousehippocampusphlebotomyinducedanemiadiminishesandtreatmentwitherythropoietinpartiallyrescuesmammaliantargetofrapamycinmtorsignaling AT alexandermichelle neonatalmousehippocampusphlebotomyinducedanemiadiminishesandtreatmentwitherythropoietinpartiallyrescuesmammaliantargetofrapamycinmtorsignaling AT enniskathleenm neonatalmousehippocampusphlebotomyinducedanemiadiminishesandtreatmentwitherythropoietinpartiallyrescuesmammaliantargetofrapamycinmtorsignaling AT tranphuv neonatalmousehippocampusphlebotomyinducedanemiadiminishesandtreatmentwitherythropoietinpartiallyrescuesmammaliantargetofrapamycinmtorsignaling AT georgieffmichaelk neonatalmousehippocampusphlebotomyinducedanemiadiminishesandtreatmentwitherythropoietinpartiallyrescuesmammaliantargetofrapamycinmtorsignaling |